Is a nuchal translucency (NT) measurement of 0.3mm considered normal in a pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

A Nuchal Translucency Measurement of 0.3mm is Abnormally Low and Likely Represents a Measurement Error

This measurement of 0.3mm is far below the expected range for any gestational age between 11-14 weeks and should prompt immediate remeasurement using proper technique. Normal NT values at this gestational window typically range from approximately 1.0-2.5mm depending on crown-rump length, making 0.3mm physiologically implausible 1, 2.

Understanding Normal NT Values

  • The American College of Radiology defines increased NT as ≥3mm or above the 99th percentile for crown-rump length, but normal NT measurements are substantially higher than 0.3mm at any point in the 11-14 week window 1, 2.

  • NT measurement is crown-rump length dependent and must be obtained between 11+0 to 14+0 weeks of gestation, as the measurement loses predictive value outside this narrow window 2, 3.

  • The hypoechoic space between the overlying skin and underlying soft tissues of the posterior cervical spine should be clearly visible and measurable, typically ranging from 1-2.5mm in normal fetuses 1, 4.

Why 0.3mm is Problematic

  • A measurement this low suggests technical error in image acquisition or caliper placement rather than a true anatomic finding 4.

  • The Nuchal Translucency Quality Review Program has established nine specific criteria for accurate NT measurement, and failure to meet these standards results in significant inter- and intra-observer variability 2, 4.

  • Quality assurance and ongoing training are essential because there is considerable measurement variability, and a 0.3mm reading falls well outside the physiologic range 2.

Immediate Next Steps

  • Request remeasurement by a certified sonographer or maternal-fetal medicine specialist using standardized Fetal Medicine Foundation techniques 2, 4.

  • Ensure the measurement is obtained with:

    • Proper fetal positioning (neutral neck position, not flexed or extended) 4
    • Adequate magnification (fetus occupying 75% of the image) 4
    • Correct caliper placement (on the inner borders of the translucent space) 4
    • Mid-sagittal plane visualization 4
  • Verify crown-rump length to confirm gestational age is within the 11-14 week window 1, 2.

Clinical Context

  • Even if remeasurement yields a normal value (1.0-2.5mm), this does not eliminate all risk—NT screening alone detects only approximately 70% of trisomy 21 cases, meaning 30% of Down syndrome fetuses will have normal NT measurements 2, 5.

  • First trimester combined screening (NT + PAPP-A + free β-hCG) should still be offered, as it detects approximately 90% of affected pregnancies with a 5% false-positive rate 1, 2.

  • A standard second trimester anatomic survey at 18-22 weeks remains mandatory regardless of first trimester NT results, as only about 50% of major fetal anomalies can be detected prior to 14 weeks 2, 5.

Common Pitfall to Avoid

  • Do not interpret an abnormally low measurement as "reassuring"—it represents technical inadequacy requiring correction 4. The measurement should be repeated until a technically adequate image meeting all quality criteria is obtained 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nuchal Translucency Screening for Fetal Abnormalities

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Nuchal Translucency Scan Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Technical aspects of nuchal translucency measurement.

Seminars in perinatology, 2005

Guideline

Early Maternal Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.